Advertisement

The Cancer Spectrum Related to Hereditary and Familial Breast and Ovarian Cancers

  • Matilde Pensabene
  • Rosaria Gesuita
  • Ida Capuano
  • Caterina Condello
  • Ilaria Spagnoletti
  • Eleonora De Maio
  • Flavia Carle
  • Stefano Pepe
  • Alma Contegiacomo
Part of the Updates in Surgery book series (UPDATESSURG)

Abstract

Multiple factors are associated with an increased risk of developing breast cancer, including age, family history, exposure to reproductive hormones, dietary factors, benign breast diseases, and environmental factors. Recently, increasing interest has been devoted to the interaction between environmental and genetic factors. Family history has been recognized as an important risk factor for developing breast cancer. Individuals with a first-degree family member affected with breast cancer have a relative risk of 2.1 (95% CI = 2.0–2.2). Moreover, risk varies with the age at which the affected relative was diagnosed, the number of affected and unaffected family members and, finally, the closeness of the relationship.

Keywords

Breast Cancer Ovarian Cancer BRCA2 Mutation Familial Breast Cancer Male Breast Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Pharoah PD, Antoniou A, Bobrow M et al (2002) Poly genic susceptibility to breast cancer and implications for prevention. Nat Genet 31:33–36PubMedCrossRefGoogle Scholar
  2. 2.
    Antoniou A, Pharaoh PD, Narod S et al (2003) Average risk of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117–1130PubMedCrossRefGoogle Scholar
  3. 3.
    Cipollini G, Tommasi S, Paradiso A et al (2004) Genetic alterations in hereditary breast cancer. Ann Oncol 15(Suppl 1):I7–I13PubMedCrossRefGoogle Scholar
  4. 4.
    Ottini L, Marsala G, D’Amico C et al (2003) BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy. Cancer Res 63(2):342–347PubMedGoogle Scholar
  5. 5.
    Marroni F, Cipollini G, Peissel B et al (2008) Reconstructing the genealogy of BRCA1 founder mutation by phylogenetic analysis. Ann Hum Genet 72(3):310–318PubMedCrossRefGoogle Scholar
  6. 6.
    Robson M, Offit K (2007) Clinical practice. Management of an inherited predisposition to breast cancer. N Engl J Med 357(2): 154–162PubMedCrossRefGoogle Scholar
  7. 7.
    Garber JE, Offit K (2005) Hereditary cancer predisposition syndromes. JCO 23(2):276–292CrossRefGoogle Scholar
  8. 8.
    Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25(11): 1329–1333PubMedCrossRefGoogle Scholar
  9. 9.
    King MC, Marks JH, Mandell JB for the New York Breast Cancer Study Group (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(24):643–646PubMedCrossRefGoogle Scholar
  10. 10.
    Lakhani SR, Jacquemier J, Sloane JP et al (1998) Multifactorial analysis of differences between sporadic breast cancer involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 90:1138–1145PubMedCrossRefGoogle Scholar
  11. 11.
    Narod SA, Foulkes WE (2004) BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 4:665–676PubMedCrossRefGoogle Scholar
  12. 12.
    Brekelmans CT, Seynaeve C, Menke-Pluymers M et al (2006) Survival and prognostic factors in BRCA1-associated breast cancer. Ann Oncol 17(3):391–400PubMedCrossRefGoogle Scholar
  13. 13.
    Rennert G, Bisland-Naggan S, Barnett-Griness O et al (2007) Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations. N Eng J Med 357:115–123CrossRefGoogle Scholar
  14. 14.
    Burke W, Daly M, Garber J et al (1997) Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA 277(12):997–1003PubMedCrossRefGoogle Scholar
  15. 15.
    Thompson D, Easton DF and the Breast Cancer Linkage Consortium (2002) Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 94(18):1358–1365PubMedGoogle Scholar
  16. 16.
    Breast Cancer Linkage Consortium (1999) Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 91(15):1310–1315CrossRefGoogle Scholar
  17. 17.
    Bermejo JL, Hemminki K (2004) Risk of cancer at sites other than the breast in Swedish families eligible for BRCA1 or BRCA2 mutation testing. Ann Oncol 15:1834–1841CrossRefGoogle Scholar
  18. 18.
    Garber JE, Syngal S (2004) One less thing to worry about: the shrinking spectrum of tumors in BRCA founder mutation carriers. J Natl Cancer Inst 96(1):2–3PubMedGoogle Scholar
  19. 19.
    Niell BL, Rennert G, Bonner JD et al (2004) BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer. J Natl Cancer Inst 96(1):15–21PubMedCrossRefGoogle Scholar
  20. 20.
    Epplein K, Koon KP, Ramsey D, Potter JD (2005) Genetic services for familial cancer patients: a follow-up survey of National Cancer Institute Cancer Centers. J Clin Oncol 23(21):4713–4718PubMedCrossRefGoogle Scholar
  21. 21.
    American Society of Clinical Oncology (2003) American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 21(15):2397–2406Google Scholar
  22. 22.
    Hopwood P, van Asperen CJ, Borreani G et al (2003) Cancer genetics service provision: a comparison of seven European centres. Community Genet 6:192–205PubMedCrossRefGoogle Scholar
  23. 23.
    Condello C, Gesuita R, Pensabene M et al (2007) Distress and family functioning in oncogenetic couselling for hereditary and familial breast and/or ovarian cancers. J Genet Couns 16(5): 625–634PubMedCrossRefGoogle Scholar
  24. 24.
    Contegiacomo A, Pensabene M, Capuano I et al on behalf of the Italian Network on Hereditary Breast Cancer (2004) An oncologist-based model of cancer genetic counseling for hereditary breast and ovarian cancer. Ann Oncol 15(5):726–732PubMedCrossRefGoogle Scholar
  25. 25.
    Domchek SM, Eisen A, Calzone K et al (2003) Application of breast cancer risk prediction model in clinical practice. J Clin Oncol 21(4):593–601PubMedCrossRefGoogle Scholar
  26. 26.
    Cortesi L, Turchetti D, Marchi I et al (2006) Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experience. BMC Cancer 6:210PubMedCrossRefGoogle Scholar
  27. 27.
    Frank TS, Deffenbaugh AM, Reid JE et al (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20(15): 1480–1490PubMedCrossRefGoogle Scholar
  28. 28.
    Berry DA, Iversen ES, Guadbjartsson DF et al (2002) BRCApro validation, sensitivity of genetic testing of BRCA1/BRCA2 and prevalence of other breast cancer susceptibility genes. J Clin Oncol 20(11):2701–2712PubMedCrossRefGoogle Scholar
  29. 29.
    Marroni F, Aretini P, D’Andrea E et al (2004) Evaluation of widely used models for predicting BRCA1 and BRCA2 mutations. J Med Genet 41:278–285PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2009

Authors and Affiliations

  • Matilde Pensabene
    • 1
  • Rosaria Gesuita
    • 1
  • Ida Capuano
    • 1
  • Caterina Condello
    • 1
  • Ilaria Spagnoletti
    • 1
  • Eleonora De Maio
    • 1
  • Flavia Carle
    • 2
  • Stefano Pepe
    • 1
  • Alma Contegiacomo
    • 1
  1. 1.Unit of Screening and Follow-up for Hereditary and Familial Cancer, Department of Molecular and Clinical Endocrinology and OncologyFederico II UniversityNaplesItaly
  2. 2.Centro di Epidemiologia, Biostatistica e Informatica MedicaUniversità Politecnica delle MarcheAnconaItaly

Personalised recommendations